| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 7,249,447 | 6,704,907 | 6,268,659 | | Cost of Revenue | 4,256,156 | 3,969,848 | 3,696,006 | | | Gross Profit | 2,993,291 | 2,735,059 | 2,572,653 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,733,622 | 1,615,819 | 1,433,733 | | Non Recurring |
-
|
-
|
-
| | Others | 37,293 | 27,904 | 10,843 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,222,376 | 1,091,336 | 1,128,077 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,979) | 6,936 | (2,919) | | Earnings Before Interest And Taxes | 1,204,428 | 1,098,731 | 1,129,727 | | Interest Expense | 185,476 | 186,329 | 96,454 | | Income Before Tax | 1,018,952 | 912,402 | 1,033,273 | | Income Tax Expense | 386,768 | 358,574 | 407,581 | | Minority Interest | (31,705) | (26,510) | (23,900) | | | | Net Income From Continuing Ops | 632,184 | 553,828 | 625,692 | | | Non-recurring Events | | Discontinued Operations | (50,694) | (213,889) | (39,271) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 581,490 | 339,939 | 586,421 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $581,490 | $339,939 | $586,421 |
|
1.48% Nasdaq 
Income Statement
